当前位置： SCI文献检索 > NATURE期刊下所有文献 > FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.

FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.

Abstract：

:Mutations in the transcription factor FOXA1 define a unique subset of prostate cancers but the functional consequences of these mutations and whether they confer gain or loss of function is unknown1-9. Here, by annotating the landscape of FOXA1 mutations from 3,086 human prostate cancers, we define two hotspots in the forkhead domain: Wing2 (around 50% of all mutations) and the highly conserved DNA-contact residue R219 (around 5% of all mutations). Wing2 mutations are detected in adenocarcinomas at all stages, whereas R219 mutations are enriched in metastatic tumours with neuroendocrine histology. Interrogation of the biological properties of wild-type FOXA1 and fourteen FOXA1 mutants reveals gain of function in mouse prostate organoid proliferation assays. Twelve of these mutants, as well as wild-type FOXA1, promoted an exaggerated pro-luminal differentiation program, whereas two different R219 mutants blocked luminal differentiation and activated a mesenchymal and neuroendocrine transcriptional program. Assay for transposase-accessible chromatin using sequencing (ATAC-seq) of wild-type FOXA1 and representative Wing2 and R219 mutants revealed marked, mutant-specific changes in open chromatin at thousands of genomic loci and exposed sites of FOXA1 binding and associated increases in gene expression. Of note, ATAC-seq peaks in cells expressing R219 mutants lacked the canonical core FOXA1-binding motifs (GTAAAC/T) but were enriched for a related, non-canonical motif (GTAAAG/A), which was preferentially activated by R219-mutant FOXA1 in reporter assays. Thus, FOXA1 mutations alter its pioneering function and perturb normal luminal epithelial differentiation programs, providing further support for the role of lineage plasticity in cancer progression.

journal_name

Nature

journal_title

Nature

authors

Adams EJ,Karthaus WR,Hoover E,Liu D,Gruet A,Zhang Z,Cho H,DiLoreto R,Chhangawala S,Liu Y,Watson PA,Davicioni E,Sboner A,Barbieri CE,Bose R,Leslie CS,Sawyers CL

doi

10.1038/s41586-019-1318-9

subject

Has Abstract

pub_date

2019-07-01 00:00:00

pages

408-412

issue

7765

eissn

0028-0836

issn

1476-4687

pii

10.1038/s41586-019-1318-9

journal_volume

571

pub_type

杂志文章

在线工具

FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.